Previous studies have reported that dysregulations in miRNA expression are implicated in β-cell dysfunction and the autoimmune destruction of pancreatic β-cells in T1D, while also affecting insulin sensitivity, and glucose metabolism in T2D [51]. The gene discussed is INS; the disease is type 1 diabetes mellitus.